HUT 8 CORP (HUT)

US44812J1043 - Common Stock

26.13  -3.49 (-11.78%)

After market: 26.4496 +0.32 (+1.22%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to HUT. HUT was compared to 278 industry peers in the Software industry. While HUT seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, HUT is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

HUT had positive earnings in the past year.
In the past year HUT has reported a negative cash flow from operations.
In multiple years HUT reported negative net income over the last 5 years.
In the past 5 years HUT reported 4 times negative operating cash flow.

1.2 Ratios

HUT has a Return On Assets of -21.28%. This is in the lower half of the industry: HUT underperforms 71.22% of its industry peers.
HUT has a Return On Equity (-25.19%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -21.28%
ROE -25.19%
ROIC N/A
ROA(3y)-18.59%
ROA(5y)-43.55%
ROE(3y)-21.83%
ROE(5y)-95.75%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

HUT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

HUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for HUT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

HUT has an Altman-Z score of 18.75. This indicates that HUT is financially healthy and has little risk of bankruptcy at the moment.
HUT's Altman-Z score of 18.75 is amongst the best of the industry. HUT outperforms 91.73% of its industry peers.
HUT has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.06, HUT perfoms like the industry average, outperforming 55.40% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 18.75
ROIC/WACCN/A
WACC11.7%

2.3 Liquidity

HUT has a Current Ratio of 6.96. This indicates that HUT is financially healthy and has no problem in meeting its short term obligations.
HUT has a Current ratio of 6.96. This is amongst the best in the industry. HUT outperforms 92.81% of its industry peers.
A Quick Ratio of 6.96 indicates that HUT has no problem at all paying its short term obligations.
The Quick ratio of HUT (6.96) is better than 93.17% of its industry peers.
Industry RankSector Rank
Current Ratio 6.96
Quick Ratio 6.96

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 145.85% over the past year.
EPS 1Y (TTM)145.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%157.57%

3.2 Future

Based on estimates for the next years, HUT will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.87% on average per year.
The Revenue is expected to grow by 122.13% on average over the next years. This is a very strong growth
EPS Next Y115.72%
EPS Next 2Y-54.17%
EPS Next 3Y15.87%
EPS Next 5YN/A
Revenue Next Year151.25%
Revenue Next 2Y101.23%
Revenue Next 3Y122.13%
Revenue Next 5YN/A

3.3 Evolution

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.19 indicates a correct valuation of HUT.
87.05% of the companies in the same industry are more expensive than HUT, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.83, HUT is valued a bit cheaper.
With a Price/Forward Earnings ratio of 139.84, HUT can be considered very expensive at the moment.
HUT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. HUT is more expensive than 60.79% of the companies in the same industry.
HUT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.65.
Industry RankSector Rank
PE 15.19
Fwd PE 139.84

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HUT's earnings are expected to grow with 15.87% in the coming years.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y-54.17%
EPS Next 3Y15.87%

0

5. Dividend

5.1 Amount

HUT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HUT 8 CORP

NASDAQ:HUT (12/18/2024, 6:56:39 PM)

After market: 26.4496 +0.32 (+1.22%)

26.13

-3.49 (-11.78%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.44B
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 15.19
Fwd PE 139.84
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.28%
ROE -25.19%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 6.96
Quick Ratio 6.96
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)145.85%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y115.72%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y